Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Liefeldt

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Journal of Hypertension|March 27, 2003
Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritisHarm Peters, Matthias Rückert, Jens Gaedeke, et al.
Circulation|May 12, 2004
Relaxin is an independent risk factor predicting death in male patients with end-stage kidney diseaseBerthold Hocher, Reinhard Ziebig, Rolfdieter Krause, et al.
Clinical Transplantation|November 15, 2006
FTY720 (fingolimod) in renal transplantationKlemens Budde, Manuela Schütz, Petra Glander, et al.
Kidney International|July 9, 2003
NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritisHarm Peters, Ute Daig, Sebastian Martini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 20, 2011
Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejectionJohannes Waiser, Klemens Budde, Manuela Schütz, et al.
Kidney International|May 20, 2004
Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritisHarm Peters, Ralph Eisenberg, Ute Daig, et al.
Drugs|July 4, 2012
Identification and therapeutic management of highly sensitized patients undergoing renal transplantationLu Huber, Nils Lachmann, Michael Dürr, et al.
Clinical Transplantation|August 14, 2012
Non-invasive imaging of living kidney donors: intraindividual comparison of multislice computed tomography angiography with magnetic resonance angiographyLutz Liefeldt, Claudia Klüner, Petra Glander, et al.
Transplantation|June 4, 2014
The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomesKaiyin Wu, Klemens Budde, Huber Lu, et al.
Kidney & Blood Pressure Research|November 22, 2008
Gender-dependent impact of risk factors for cardiovascular and non-cardiovascular mortality in end-stage renal disease patients on haemodialysisBerthold Hocher, Philipp Kalk, Michael Godes, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Journal of Hypertension|March 27, 2003
Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritisHarm Peters, Matthias Rückert, Jens Gaedeke, et al.
Circulation|May 12, 2004
Relaxin is an independent risk factor predicting death in male patients with end-stage kidney diseaseBerthold Hocher, Reinhard Ziebig, Rolfdieter Krause, et al.
Clinical Transplantation|November 15, 2006
FTY720 (fingolimod) in renal transplantationKlemens Budde, Manuela Schütz, Petra Glander, et al.
Kidney International|July 9, 2003
NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritisHarm Peters, Ute Daig, Sebastian Martini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 20, 2011
Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejectionJohannes Waiser, Klemens Budde, Manuela Schütz, et al.
Kidney International|May 20, 2004
Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritisHarm Peters, Ralph Eisenberg, Ute Daig, et al.
Drugs|July 4, 2012
Identification and therapeutic management of highly sensitized patients undergoing renal transplantationLu Huber, Nils Lachmann, Michael Dürr, et al.
Clinical Transplantation|August 14, 2012
Non-invasive imaging of living kidney donors: intraindividual comparison of multislice computed tomography angiography with magnetic resonance angiographyLutz Liefeldt, Claudia Klüner, Petra Glander, et al.
Transplantation|June 4, 2014
The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomesKaiyin Wu, Klemens Budde, Huber Lu, et al.
Kidney & Blood Pressure Research|November 22, 2008
Gender-dependent impact of risk factors for cardiovascular and non-cardiovascular mortality in end-stage renal disease patients on haemodialysisBerthold Hocher, Philipp Kalk, Michael Godes, et al.
Pageof 8